In addition to enhancing angiogenesis and lymphangiogenesis, Pim kinases are likely to promote metastatic prostate cancer growth by employing the CXCL12/CXCR4 chemokine pathway. This evidence concerns the gene CXCR4 and Familial prostate cancer.